vs
CS Disco, Inc.（LAW）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
CS Disco, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍（$41.2M vs $35.5M），CS Disco, Inc.净利率更高（-20.7% vs -304.2%，领先283.6%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 11.3%），CS Disco, Inc.自由现金流更多（$255.0K vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 7.6%）
CS Disco, Inc.是一家领先的法律科技企业，开发面向法律从业者的云原生软件产品，涵盖电子取证、文档审核、案件管理及法律工作流自动化等工具，服务客户包括律师事务所、企业法务部门及政府法律机构。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
LAW vs RXRX — 直观对比
营收规模更大
LAW
是对方的1.2倍
$35.5M
营收增速更快
RXRX
高出670.5%
11.3%
净利率更高
LAW
高出283.6%
-304.2%
自由现金流更多
LAW
多$47.6M
$-47.3M
两年增速更快
RXRX
近两年复合增速
7.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.2M | $35.5M |
| 净利润 | $-8.5M | $-108.1M |
| 毛利率 | 75.1% | 59.8% |
| 营业利润率 | -22.4% | -304.8% |
| 净利率 | -20.7% | -304.2% |
| 营收同比 | 11.3% | 681.7% |
| 净利润同比 | 66.3% | 39.6% |
| 每股收益（稀释后） | $-0.13 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LAWRXRX
| Q4 25 | $41.2M | $35.5M | ||
| Q3 25 | $40.9M | $5.2M | ||
| Q2 25 | $38.1M | $19.2M | ||
| Q1 25 | $36.7M | $14.7M | ||
| Q4 24 | $37.0M | $4.5M | ||
| Q3 24 | $36.3M | $26.1M | ||
| Q2 24 | $36.0M | $14.4M | ||
| Q1 24 | $35.6M | $13.8M |
净利润LAWRXRX
| Q4 25 | $-8.5M | $-108.1M | ||
| Q3 25 | $-13.7M | $-162.3M | ||
| Q2 25 | $-10.8M | $-171.9M | ||
| Q1 25 | $-11.4M | $-202.5M | ||
| Q4 24 | $-25.2M | $-178.9M | ||
| Q3 24 | $-9.2M | $-95.8M | ||
| Q2 24 | $-10.8M | $-97.5M | ||
| Q1 24 | $-10.6M | $-91.4M |
毛利率LAWRXRX
| Q4 25 | 75.1% | 59.8% | ||
| Q3 25 | 75.5% | -183.8% | ||
| Q2 25 | 74.6% | -4.9% | ||
| Q1 25 | 74.1% | -48.0% | ||
| Q4 24 | 74.2% | -181.4% | ||
| Q3 24 | 73.1% | 53.7% | ||
| Q2 24 | 74.2% | 36.2% | ||
| Q1 24 | 75.1% | 19.1% |
营业利润率LAWRXRX
| Q4 25 | -22.4% | -304.8% | ||
| Q3 25 | -35.3% | -3327.6% | ||
| Q2 25 | -31.0% | -916.8% | ||
| Q1 25 | -34.4% | -1297.9% | ||
| Q4 24 | -70.6% | -4042.4% | ||
| Q3 24 | -30.0% | -377.1% | ||
| Q2 24 | -34.4% | -697.4% | ||
| Q1 24 | -34.7% | -698.4% |
净利率LAWRXRX
| Q4 25 | -20.7% | -304.2% | ||
| Q3 25 | -33.4% | -3135.3% | ||
| Q2 25 | -28.4% | -894.2% | ||
| Q1 25 | -31.1% | -1373.3% | ||
| Q4 24 | -68.1% | -3935.5% | ||
| Q3 24 | -25.3% | -367.5% | ||
| Q2 24 | -30.1% | -676.6% | ||
| Q1 24 | -29.7% | -662.4% |
每股收益（稀释后）LAWRXRX
| Q4 25 | $-0.13 | $-0.17 | ||
| Q3 25 | $-0.22 | $-0.36 | ||
| Q2 25 | $-0.18 | $-0.41 | ||
| Q1 25 | $-0.19 | $-0.50 | ||
| Q4 24 | $-0.43 | $-0.56 | ||
| Q3 24 | $-0.15 | $-0.34 | ||
| Q2 24 | $-0.18 | $-0.40 | ||
| Q1 24 | $-0.17 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $114.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $128.1M | $1.1B |
| 总资产 | $173.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资LAWRXRX
| Q4 25 | $114.6M | $743.3M | ||
| Q3 25 | $113.5M | $659.8M | ||
| Q2 25 | $114.5M | $525.1M | ||
| Q1 25 | $118.8M | $500.5M | ||
| Q4 24 | $129.1M | $594.4M | ||
| Q3 24 | $126.8M | $427.6M | ||
| Q2 24 | $130.0M | $474.3M | ||
| Q1 24 | $148.7M | $296.3M |
总债务LAWRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益LAWRXRX
| Q4 25 | $128.1M | $1.1B | ||
| Q3 25 | $130.6M | $1.0B | ||
| Q2 25 | $137.9M | $919.1M | ||
| Q1 25 | $142.2M | $933.9M | ||
| Q4 24 | $147.5M | $1.0B | ||
| Q3 24 | $167.3M | $524.6M | ||
| Q2 24 | $170.9M | $584.4M | ||
| Q1 24 | $193.2M | $401.2M |
总资产LAWRXRX
| Q4 25 | $173.6M | $1.5B | ||
| Q3 25 | $174.8M | $1.4B | ||
| Q2 25 | $164.9M | $1.3B | ||
| Q1 25 | $168.0M | $1.3B | ||
| Q4 24 | $180.3M | $1.4B | ||
| Q3 24 | $194.4M | $726.5M | ||
| Q2 24 | $198.0M | $775.9M | ||
| Q1 24 | $217.3M | $557.8M |
负债/权益比LAWRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $762.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $255.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | 0.6% | -133.1% |
| 资本支出强度资本支出/营收 | 1.2% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-18.0M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流LAWRXRX
| Q4 25 | $762.0K | $-46.1M | ||
| Q3 25 | $-979.0K | $-117.4M | ||
| Q2 25 | $-4.2M | $-76.4M | ||
| Q1 25 | $-10.5M | $-132.0M | ||
| Q4 24 | $2.1M | $-115.4M | ||
| Q3 24 | $-2.9M | $-59.2M | ||
| Q2 24 | $-650.0K | $-82.2M | ||
| Q1 24 | $-7.3M | $-102.3M |
自由现金流LAWRXRX
| Q4 25 | $255.0K | $-47.3M | ||
| Q3 25 | $-2.0M | $-117.6M | ||
| Q2 25 | $-5.2M | $-79.6M | ||
| Q1 25 | $-11.0M | $-133.8M | ||
| Q4 24 | $1.5M | $-116.7M | ||
| Q3 24 | $-3.7M | $-63.8M | ||
| Q2 24 | $-1.3M | $-83.4M | ||
| Q1 24 | $-8.0M | $-109.0M |
自由现金流率LAWRXRX
| Q4 25 | 0.6% | -133.1% | ||
| Q3 25 | -5.0% | -2272.5% | ||
| Q2 25 | -13.6% | -413.9% | ||
| Q1 25 | -30.1% | -907.4% | ||
| Q4 24 | 4.1% | -2567.7% | ||
| Q3 24 | -10.3% | -244.6% | ||
| Q2 24 | -3.6% | -578.5% | ||
| Q1 24 | -22.5% | -789.9% |
资本支出强度LAWRXRX
| Q4 25 | 1.2% | 3.5% | ||
| Q3 25 | 2.6% | 4.7% | ||
| Q2 25 | 2.5% | 16.4% | ||
| Q1 25 | 1.4% | 12.4% | ||
| Q4 24 | 1.5% | 28.6% | ||
| Q3 24 | 2.4% | 17.5% | ||
| Q2 24 | 1.8% | 8.2% | ||
| Q1 24 | 1.9% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAW
| Software | $35.1M | 85% |
| Services | $6.0M | 15% |
RXRX
暂无分部数据
